Johns Hopkins Medicine

FOR US AUDIENCES ONLY

Johns Hopkins Medicine

The first president of Johns Hopkins University, Daniel Coit Gilman, believed that teaching and research go hand in hand. He presumed that success in one depends on success in the other. He also believed that sharing knowledge and discoveries would help make the world a better place.

That’s why our team was very pleased to visit Johns Hopkins Medicine to introduce the clinic to our new technology in tubal patency testing for women with known or suspected infertility. This Foam procedure offers a less complicated, less invasive alternative to the gold standard for diagnosing tubal patency – laparoscopy.1

We are working tirelessly to visit and train new US facilities, virtually and, where possible, in-person. Don’t hesitate to reach out for more information about ExEm® Foam ((air polymer-type A) intrauterine foam) and follow us on LinkedIn for the latest updates.

lwolfe632021-09-02T00:07:06+00:00

ExEm® Foam is an innovative, FDA-approved product that offers a less invasive and effective alternative to other tubal patency assessment procedures, like laparoscopy or X-Ray HSG.

ExEm^® Foam Inc. is an affiliate of IQ MEDICAL VENTURES, B.V. ExEm^® is a registered trademark of GISKIT PHARMA B.V.

Important Safety Information: ExEm^® Foam should not be used on patients who are pregnant, have known or suspected lower genital tract inflammation or infection, have had a gynecologic procedure within the last 30 days, have vaginal bleeding, or have known or suspected reproductive tract neoplasia. Common side effects include pelvic and abdominal pain, vasovagal reactions (and associated symptoms such as nausea and faintness), and post-procedure spotting. Click here for full prescribing information.

References:

‍1. Ludwin I., Ludwin, A. et al. Accuracy of hysterosalpingo-foam sonography in comparison to hysterosalpingo-contrast sonography with air/saline and to laparoscopy with dye. Human Reproduction 2017, 32(4):758–69
‍
‍2. Riganelli L., Casorelli A. et al. Ultrasonography reappraisal of tubal patency in assisted reproduction technology patients: comparison between 2D and3D-sonohysterosalpingography. A pilot study. Minerva Ginecologica 2018, 70(2):123-28
‍
3. Dreyer, K., Out, R. et al. Hysterosalpingo-foam sonography, a less painful procedure for tubal patency testing during fertility workup compared with (serial) hysterosalpingography: A randomized controlled trial. Fertility and Sterility 2014, 102(3):821-25

ExEm_US_02_v27

ExEm^® Foam Inc. is an affiliate of IQ MEDICAL VENTURES, B.V. ExEm^® is a registered trademark of GISKIT PHARMA B.V.